Litcius/Paper detail

Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella, C. Sassaroli, Massimo Framarini, Mario Valle, Antonio Macrì, Luigina Graziosi, Federico Coccolini, Piero Vincenzo Lippolis, Roberta Gelmini, Marcello Deraco, Daniele Biacchi, Francesco Santullo, Marco Vaira, Katia Di Lauro, Fabrizio D’Acapito, Fabio Carboni, Giuseppe Giuffrè, Annibale Donini, Paola Fugazzola, Pinuccia Faviana, Lorena Sorrentino, Antonio Scapinello, Paola Del Bianco, Antonio Sommariva

2021Annals of Surgical Oncology31 citationsDOIOpen Access PDF

Topics & Concepts

MedicineKRASSurgical oncologyHyperthermic intraperitoneal chemotherapyInternal medicineOncologyNeuroblastoma RAS viral oncogene homologMicrosatellite instabilityColorectal cancerChemotherapyGastroenterologyConfidence intervalCytoreductive surgeryCancerOvarian cancerGeneBiochemistryChemistryAlleleMicrosatelliteIntraperitoneal and Appendiceal MalignanciesOccupational and environmental lung diseasesNanoplatforms for cancer theranostics
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | Litcius